Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

18.14 +0.07 (+0.39%)
Official Closing Price Updated: 7:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
News headline image
Should You Buy the SpaceX IPO? History Says the Stock Will Make a Big Move in the First Year. ↗
Historically, large IPO stocks have often declined during their first year on the public market. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Stocks
News headline image
Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning Anyway ↗
These stocks may deliver gains during any market environment. 
Via The Motley Fool
Topics Artificial Intelligence Government Initial Public Offering
News headline image
The SpaceX IPO Is Just Days Away. History Says the Stock Will Do This When It Starts Trading. ↗
The 10 largest U.S. IPO stocks in history have collectively underperformed the S&P 500 by a wide margin. 
Via The Motley Fool
Topics Initial Public Offering Stocks
Kenvue (NYSE:KVUE) Earnings Beat Driven by Margin Expansion Amidst Pending Kimberly-Clark Acquisition ↗
Via Chartmill
Topics Earnings
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
News headline image
3 Dividend Kings That Earn Their Crown Every Quarter ↗
These 3 Dividend Kings combine decades of dividend growth with strong fundamentals, recession resistance, and long-term income potential 
Via MarketBeat
Topics Economy
News headline image
Stock Market Crash: The Best Dividend Stocks to Buy Right Now ↗
Both of these two sport dividend yields above 5%. 
Via The Motley Fool
Topics Economy
News headline image
These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocks ↗
Consumer defensive stocks with a solid dividend history could serve investors well regardless of what happens to the market. 
Via The Motley Fool
News headline image
These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again. ↗
History doesn't guarantee anything in the stock market. But when a company has paid dividends through recessions, wars, pandemics, and inflationary cycles, and still raises its payout, that's a signal... 
Via The Motley Fool
News headline image
Kenvue Reports First Quarter 2026 Results
From Kenvue
Via Business Wire
News headline image
The Best Dividend Stock to Own During a Market Crash ↗
This consumer staples stock should remain resilient no matter what happens with the market. 
Via The Motley Fool
Topics Economy
News headline image
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
News headline image
Kimberly-Clark (KMB) Q1 2026 Earnings Transcript ↗
Kimberly-Clark (KMB) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Economy
News headline image
Kenvue Stock: Is Wall Street Bullish or Bearish?
Kenvue has underperformed the broader market over the past year, and analysts remain skeptical about the stock’s prospects. 
Via Barchart.com
Topics ETFs
Want Reliable Dividend Income? These 3 Stocks Yield 5% and Have Been Raising Their Payouts for Decades ↗
Via The Motley Fool
News headline image
Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64% ↗
Daniel Loeb trims major stake in Kenvue as company advances restructuring and prepares for acquisition by Kimberly-Clark. 
Via Benzinga
News headline image
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
From Kenvue
Via Business Wire
News headline image
Here's What to Expect From Kenvue's Next Earnings Report
Kenvue will release its first-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth. 
Via Barchart.com
Topics ETFs
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
Growth stocks may be on fire again, but if you needed dividend stocks then, you still need them now. Here's a look at three of the best bets at this time. 
Via The Motley Fool
News headline image
Meet the Dividend King That Just Raised Its Payout For the 70th Consecutive Year. Here's Why It's a No-Brainer Buy Before the End of April. ↗
Decades of dividend increases and a 3% yield make Procter & Gamble a passive-income powerhouse. 
Via The Motley Fool
Topics Economy
News headline image
3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
Johnson & Johnson, Abbott Laboratories, and Becton, Dickinson don't fall as far as other healthcare stocks and bounce back faster during economic downturns. 
Via The Motley Fool
Topics Economy
News headline image
Skip the 10-Year Bond? 3 Dividend Aristocrats to Consider Now ↗
Three Dividend Aristocrats offer yields above the 10-year Treasury while delivering income growth and potential capital appreciation 
Via MarketBeat
Topics Bonds Earnings Economy
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
This Value Stock Yields 5.3% and Has Paid a Dividend for 92 Consecutive Years. Here's Why It's a Buy in April. ↗
Kimberly Clark is a worthy foundational holding in a passive-income portfolio. 
Via The Motley Fool
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The New J&J: A 2026 Deep Dive into the Global Healthcare Titan
As of April 14, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different entity than it was only three years ago. Following the successful spin-off of its consumer health division, Kenvue,... 
Via Finterra
Topics Artificial Intelligence Death Economy
News headline image
Better Buy Right Now: Johnson & Johnson Vs. Pfizer ↗
The choice is based on more than just the dividend payout. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down ↗
These defensive consumer stocks are flashing buy signals while the market chases AI hype. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Wall Street's Great Rotation: Goldman and JPMorgan Pivot to 'Innovation Supercycle' as Interest Income Peaks
As the sun sets on the era of easy profits from elevated interest rates, the titans of Wall Street are preparing to unveil a new chapter in their growth stories. For the first time in three years, the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.